The answer depends entirely on how you define “disease” and who is doing the counting. The World Health Organization’s latest International Classification of Diseases contains roughly 14,600 codable disease and condition categories, but that number reflects administrative choices about how finely to slice medical reality, not a clean census of nature. Other systems produce wildly different tallies, from the few hundred conditions that drive most of the world’s suffering to the tens of thousands of genetic disorders catalogued in specialized databases. The honest answer is that there is no single, agreed-upon number, and the reasons why tell you more about the state of medicine than any figure could.
Nobody Agrees on What Counts as a Disease
The question sounds straightforward, but it hits a wall almost immediately: medicine has never settled on a crisp definition of “disease.” Philosophers of medicine have argued for generations about where health ends and disease begins, and the debate is far from settled. Some scholars have argued forcefully that no clear line can be drawn at all between health and disease, because the boundary is inherently fuzzy.1PubMed Central. How to Draw the Line Between Health and Disease? Start with Suffering. Others have pointed out that “disease” is what philosophers call a cluster concept, meaning it resists any tidy set of necessary and sufficient conditions, and has genuine borderline cases where reasonable people will disagree.2The Journal of Medicine and Philosophy. Boundaries of Disease: Vagueness and Overdiagnosis
This is not just an academic puzzle. It has real consequences for counting. Is high blood pressure a disease or a risk factor? Is alcoholism a disease, a behavioral pattern, or both? Is aging itself a disease? Some researchers have pushed the WHO to classify aging as a disease, while others have argued there is no scientific support for doing so and that the move would undermine healthy-aging frameworks.3PubMed Central. Is Aging a Disease? A Critical Review Within the Framework of Ageism Even the term “disease” itself lacks an unambiguous, generally accepted definition in the medical literature, a problem that has been noted for decades without resolution.4PubMed Central. Diagnoses, syndromes, and diseases: a knowledge representation problem. So when someone quotes a total number of diseases, the first thing to ask is what they decided to include.
The Major Counting Systems and Their Wildly Different Numbers
Several large-scale systems attempt to catalogue human diseases, and each produces a different count because each serves a different purpose.
The most widely used is the WHO’s International Classification of Diseases. The latest version, ICD-11, contains about 14,622 “leaf codes,” meaning categories specific enough to be used in actual medical coding. Its predecessor, ICD-10, had around 10,607, while the United States’ clinical modification of ICD-10 (ICD-10-CM) exploded the count to nearly 72,000 codes by adding enormous clinical detail for billing and documentation purposes.5PubMed Central. The new International Classification of Diseases 11th edition: a comparative analysis with ICD-10 and ICD-10-CM That seven-fold difference between ICD-11 and ICD-10-CM is not because the U.S. has discovered tens of thousands of diseases that the rest of the world missed. It’s because the American system slices conditions into much finer categories, often distinguishing between the same injury on the left versus the right side of the body, or the same fracture at slightly different anatomical sites. The ICD-11 itself sits on top of a deeper knowledge base called the Foundation, which acts as a kind of semantic backbone linking diseases, anatomy, and causes in a more flexible way than previous editions.6PubMed Central. ICD-11: an international classification of diseases for the twenty-first century
At the other end of the spectrum, the Global Burden of Disease Study, one of the most ambitious public health projects ever undertaken, tracks just 369 diseases and injuries across 204 countries.7PubMed Central. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 That small number is deliberate. The GBD organizes conditions into a hierarchy, with three broad top-level categories (communicable diseases, non-communicable diseases, and injuries), 22 second-level causes, 174 third-level causes, and 301 of the most specific fourth-level causes.8The Lancet. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 The goal is not comprehensiveness but comparability: the GBD needs categories that can be consistently measured across every country, which means lumping many rare or hard-to-track conditions together.
Then there are the genetics-focused databases. The Online Mendelian Inheritance in Man catalogue, OMIM, contained over 22,600 entries as of 2014, describing nearly 14,800 genes and about 7,900 distinct phenotypes (observable traits or conditions linked to genetic causes).9Nucleic Acids Research. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders That number has continued to grow as genomic sequencing has gotten cheaper and faster. Some of those phenotypes are recognized clinical diseases; others are traits or predispositions that shade into disease under certain circumstances. No single number from any of these systems captures the true total, because each system answers a subtly different version of the question.
Rare Diseases Make Up Most of the List
Here is a paradox that catches many people off guard: rare diseases are individually uncommon, but collectively they make up the vast majority of recognized disease entities. Estimates of how many rare diseases exist generally land somewhere between 7,000 and 10,000, though the upper bound keeps climbing as genetic research identifies new conditions.10PubMed Central. How many rare diseases are there? Many of these affect only a handful of people worldwide, and some have been documented in just a single family. If you ever looked at the ICD’s 14,600 codes and wondered what could possibly fill all those categories, the answer is largely rare genetic conditions, unusual infections, and narrowly defined subtypes of more common diseases.
This has practical implications. Because rare diseases are so numerous and so individually obscure, getting an accurate diagnosis can take years. Many patients cycle through multiple specialists before anyone recognizes the pattern. And new rare diseases are still being found at a steady clip. A 2022 study using a gene-to-patient approach identified 18 putative novel disease genes from a large set of patient trios, and within two years, 11 of those 18 had been independently confirmed as genuine new disease-gene discoveries.11PubMed Central. A gene-to-patient approach uplifts novel disease gene discovery and identifies 18 putative novel disease genes The total number of diseases is not fixed. It is growing, mostly at the rare-disease end.
Molecular Science Keeps Splitting What We Thought Were Single Diseases
Cancer is the clearest example of a broader trend: what used to be treated as one disease often turns out to be many. Traditional cancer diagnosis was based on where the tumor originated and how the cells looked under a microscope. But molecular profiling has revealed that a single diagnostic label can hide enormous biological diversity. Non-small cell lung cancer, for instance, which was long treated as a single disease category, may actually comprise up to 100 different molecular entities, each driven by different genetic changes and potentially responding to different treatments.12PubMed. Molecular profiling and the reclassification of cancer: divide and conquer
This kind of splitting is not limited to cancer. In genetics, there is an ongoing tension between “lumpers” and “splitters,” a debate about whether to classify conditions broadly or narrowly. A recent analysis found that some expert groups tend to split gene-disease associations based on narrow phenotypic features of interest, driven partly by clinical testing practices like the gene panels labs offer for specific symptoms, rather than curating for the broader underlying condition.13PubMed Central. Lumping versus splitting: How to approach defining a disease to enable accurate genomic curation The result is that the same underlying biological process can be classified as one disease or as several, depending on which specialty is looking at it and what clinical question they are trying to answer. Every time a disease gets split into molecularly distinct subtypes, the total disease count goes up, even though nothing about the patients has changed.
Infectious Disease and the Expanding Pathogen Pool
On the infectious side of medicine, counting diseases often starts with counting the organisms that cause them. A comprehensive database compiled in the early 2000s catalogued 1,415 species of pathogens known to cause disease in humans, ranging from viruses and bacteria to fungi, protozoa, and helminths (parasitic worms).14PubMed Central. Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence But one pathogen can cause multiple diseases (the same bacterium might cause skin infections, pneumonia, and bloodstream infections), and some diseases are caused by multiple pathogens (pneumonia can result from dozens of different organisms). So the pathogen count and the disease count are related but not interchangeable.
New infectious diseases keep appearing. A study testing over half a million animal samples as part of a virus discovery project ranked the spillover potential of 887 wildlife viruses, assessing how likely each was to jump into human populations.15PNAS. Ranking the risk of animal-to-human spillover for newly discovered viruses Not all of these will become human diseases, but the pipeline of potential new pathogens is large. When one does make the jump, it creates a genuinely new disease that did not exist in any classification system the year before. COVID-19 is the most dramatic recent example, but new viral and bacterial diseases are identified at a lower-profile rate every year.
Modern medicine can also create new diseases unintentionally. Novel biological drugs and cancer immunotherapies have led to a rise in immune-related adverse events affecting the central nervous system, including drug-related inflammatory disorders of the spinal cord that were essentially unheard of before these therapies existed.16PubMed Central. Drug-related immune-mediated myelopathies These iatrogenic conditions (diseases caused by medical treatment) add to the total count, a side effect of therapeutic progress.
Conditions That Exist in Some Cultures but Not Others
Western biomedical classification systems are not the only way to organize human suffering. Across the world, dozens of conditions recognized by local cultures resist easy mapping onto ICD codes. These are sometimes called culture-bound syndromes, and they represent a genuine challenge to the question of how many diseases exist. Literally dozens of such syndromes have been described globally, and there is considerable looseness in how the term is applied.17PubMed. Culture-bound syndromes and international disease classifications
In a Brazilian Amazon riverine population, researchers documented eight culture-bound syndromes including “mau olhado” (evil eye), “espante” (fright), and “panema” (a state of chronic unluckiness). Some of these turned out to correspond reasonably well to known biomedical conditions, while others, like panema, appeared to be distinct entities possibly related to depression but not clearly matching any Western diagnostic category.18PubMed. Culture-Bound Syndromes of a Brazilian Amazon Riverine population: Tentative correspondence between traditional and conventional medicine terms and possible ethnopharmacological implications Ethnomedicine is inherently culture-bound, and applying Western biomedical classification schemes to local disease concepts often misses the point.19PubMed. Classifying diseases and remedies in ethnomedicine and ethnopharmacology Whether these syndromes “count” as diseases depends on whether you are counting from a biomedical perspective or a more inclusive one. If you include them, the number goes up, though by how much is genuinely unclear.
Mental Health Adds Another Layer of Complexity
Mental health conditions illustrate the definition problem in a particularly vivid way. The Diagnostic and Statistical Manual of Mental Disorders, the standard reference in American psychiatry, has gone through multiple editions since 1980, and over roughly 40 years, it has offered six different definitions of what a “mental disorder” even is.20PubMed Central. Definitions of “Mental Disorder” from DSM-III to DSM-5. The number of recognized disorders has grown with each edition, partly because of genuine scientific discovery and partly because the diagnostic net has widened. Conditions that were once considered personality quirks or normal variations in temperament have, over time, been reclassified as disorders.
Autoimmune conditions present a similar counting challenge. Over 100 autoimmune diseases are commonly listed by advocacy groups and health agencies, but the line between autoimmunity (having self-reactive immune components) and autoimmune disease (having autoimmunity plus actual tissue damage) is not always sharp.21PubMed Central. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention Many people have detectable autoantibodies without any symptoms. Whether their immune quirk is a “disease” depends on where you set the threshold.
Diseases That Have Disappeared
While new diseases keep appearing, a very small number have been erased entirely. Smallpox was the first infectious disease formally declared eradicated, in 1980, and it holds several historical firsts: the first disease targeted by a vaccine, the first to be completely eliminated, and the first viral infection treated with effective antiviral chemotherapy.22Human Virology. Smallpox: human disease eradicated but zoonotic pox virus infections common The second infectious disease to be eradicated was rinderpest, a devastating cattle plague, declared eliminated in 2011.23PubMed. Scientific background to the global eradication of rinderpest
That is the entire list: two diseases, in all of human history, have been permanently removed from the world. Several others are targets of eradication campaigns (Guinea worm disease, polio), but none has yet crossed the finish line. The arithmetic is sobering. The world adds new recognized diseases every year through genetic discovery, pathogen spillover, and diagnostic refinement, while removing them from the list at a pace of roughly one per generation. The total trends upward, and the rate of addition is accelerating as genomic tools get more powerful.
Why the Number Keeps Growing
Putting all of this together, the total count of recognized human diseases is probably somewhere between 10,000 and 15,000 if you use the ICD-11 as your baseline, higher if you include the fine-grained subtypes that molecular profiling and genetics have revealed, and lower if you restrict yourself to conditions that carry a meaningful burden at the population level. The GBD’s 369 conditions capture the vast majority of global death and disability despite being a tiny fraction of the total catalogue, which tells you something about how top-heavy the distribution is: a few hundred common diseases cause most of the suffering, while thousands of rare conditions collectively affect a comparatively small number of people.
The trend is clearly toward more recognized diseases, not fewer. Genomic sequencing turns what was once “a child with developmental delays” into a specific named syndrome with a known molecular cause. Molecular profiling splits a single cancer diagnosis into dozens of distinct entities. New pathogens spill over from animals. Novel therapies produce novel side effects. And researchers working in understudied populations continue to document conditions that do not appear in any existing classification system. The question “how many diseases are there?” does not have a stable answer. It has a moving target that drifts upward as medicine’s resolution improves, like turning up the magnification on a microscope and finding detail that was always there but invisible at the previous setting.